There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
There are few data about the cost effectiveness of prophylactic medications for migraine.
Clinical trials have shown several preventive agents to be useful in reducing the
frequency of migraine attack while having tolerable side effects.